Compare · CAI vs HUM
CAI vs HUM
Side-by-side comparison of Caris Life Sciences Inc. (CAI) and Humana Inc. (HUM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CAI and HUM operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $46.33B, about 8.3x CAI ($5.59B).
- HUM has been more active in the news (18 items in the past 4 weeks vs 4 for CAI).
- HUM has more recent analyst coverage (25 ratings vs 16 for CAI).
- Company
- Caris Life Sciences Inc.
- Humana Inc.
- Price
- -
- -
- Market cap
- $5.59B
- $46.33B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 4
- 18
- Recent ratings
- 16
- 25
Caris Life Sciences Inc.
CAI International, Inc. operates as a transportation finance company in the United States, Switzerland, France, Korea, Singapore, rest of Asia, rest of Europe, and internationally. The company leases, re-leases, and disposes equipment; and contracts for the repair, repositioning, and storage of equipment. It leases its container equipment to lessees under long-term, short-term, and finance leases. The company also sells containers; and manages equipment for to third-party investors, as well as sells used containers. As of December 31, 2020, it had a container fleet comprised 1,798,520 cost equivalent units. The company was formerly known as Container Applications International, Inc. and changed its name to CAI International, Inc. in February 2007. CAI International, Inc. was incorporated in 1989 and is headquartered in San Francisco, California.
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Latest CAI
- Amendment: SEC Form SCHEDULE 13G/A filed by Caris Life Sciences Inc.
- SEC Form 10-Q filed by Caris Life Sciences Inc.
- Caris Life Sciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Caris Life Sciences Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
- Caris Life Sciences Launches New National Commercial Featuring Jordan Spieth Highlighting the Power of Artificial Intelligence in Early Stage Cancer Detection
- Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026
- Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026
- Officer Denton John Russel sold $238,626 worth of shares (7,500 units at $31.82), decreasing direct ownership by 4% to 174,855 units (SEC Form 4)
- Officer Brille Brian J exercised 400,000 shares at a strike of $2.44 and sold $12,132,080 worth of shares (400,000 units at $30.33) (SEC Form 4)
- Caris Life Sciences Inc. filed SEC Form 8-K: Regulation FD Disclosure
Latest HUM
- Florida Seniors and Primary Care Providers Agree that Prevention, Affordable Care and Comprehensive Coverage are Keys to Healthy Aging
- Humana Foundation Marks 45 Years With Nearly $14 Million in Grants to Expand Healthy Food Access and Help Seniors Feel More Connected
- Humana to Launch National Gold Card Program to Reduce Prior Authorization Requirements
- Humana Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Humana Announces Final Results of Offers to Purchase for Cash Certain of its Outstanding Debt Securities
- Humana Announces Pricing Terms of Offers to Purchase for Cash Certain of its Outstanding Debt Securities
- Humana upgraded by RBC Capital Mkts with a new price target
- Director Frederick Wayne A.I. sold $193,853 worth of Humana Common (440 units at $440.57), closing all direct ownership in the company (SEC Form 4)
- President, Enterprise Growth Dintenfass David gifted 230 units of Humana Common, decreasing direct ownership by 0.91% to 25,177 units (SEC Form 4)
- Chief Legal Officer Ventura Joseph C sold $2,384,013 worth of Humana Common (5,495 units at $433.85) and gifted 437 units of Humana Common, decreasing direct ownership by 22% to 21,473 units (SEC Form 4)